Safety, tolerability, and efficacy of pirfenidone in patients with rheumatoid arthritis-associated interstitial lung disease: a randomised, double-blind, placebo-controlled, phase 2 study - Solomon, J J; Danoff, S K; Woodhead, F A; TRAIL1 Network Investigators (Lancet Respir Med, 2023)